Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor

Document Type

Journal Article

Publication Date

2011

Journal

Molecular Cancer Therapeutics

Volume

8

Issue

5

Inclusive Pages

1137-1147

Keywords

Pediatrics

This document is currently not available here.

Share

COinS